These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37435503)

  • 1. Dispensing mifepristone for medical abortion in Canada: Pharmacists' experiences of the first year.
    Zusman EZ; Munro S; Norman WV; Soon JA
    Can Pharm J (Ott); 2023; 156(4):204-214. PubMed ID: 37435503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "No Big Deal": A Qualitative Study of Pharmacists' Perspectives on Dispensing Mifepristone for Medication Abortion.
    Kaller S; Ma M; Gurazada T; Baba CF; Rafie S; Raine-Bennett T; Averbach S; Chen M; Berry E; Meckstroth KR; Grossman D
    Womens Health Issues; 2022; 32(6):571-577. PubMed ID: 35918240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist direct dispensing of mifepristone for medication abortion in Canada: a survey of community pharmacists.
    Zusman EZ; Munro S; Norman WV; Soon JA
    BMJ Open; 2022 Oct; 12(10):e063370. PubMed ID: 36207038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists' knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion.
    Kaller S; Morris N; Biggs MA; Baba CF; Rafie S; Raine-Bennett TR; Creinin MD; Berry E; Micks EA; Meckstroth KR; Averbach S; Grossman D
    J Am Pharm Assoc (2003); 2021; 61(6):785-794.e1. PubMed ID: 34281806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist dispensing of the abortion pill in Canada: Diffusion of Innovation meets integrated knowledge translation.
    Munro S; Wahl K; Soon JA; Guilbert E; Wilcox ES; Leduc-Robert G; Ansari N; Devane C; Norman WV
    Implement Sci; 2021 Aug; 16(1):76. PubMed ID: 34344393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists' experiences dispensing misoprostol and readiness to dispense mifepristone.
    Ferketa M; Moore A; Klein-Barton J; Stulberg D; Hasselbacher L
    J Am Pharm Assoc (2003); 2024; 64(1):245-252.e1. PubMed ID: 37913990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama.
    Sisson ML; McMahan KB; Chichester KR; Galbraith JW; Cropsey KL
    Int J Drug Policy; 2019 Dec; 74():229-235. PubMed ID: 31698165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication abortion: Potential for improved patient access through pharmacies.
    Raifman S; Orlando M; Rafie S; Grossman D
    J Am Pharm Assoc (2003); 2018; 58(4):377-381. PubMed ID: 29752204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mail-Order Pharmacy Dispensing of Mifepristone for Medication Abortion After In-Person Screening.
    Grossman D; Raifman S; Morris N; Arena A; Bachrach L; Beaman J; Biggs MA; Collins A; Hannum C; Ho S; Seibold-Simpson SM; Sobota M; Tocce K; Schwarz EB; Gold M
    JAMA Intern Med; 2024 May; ():. PubMed ID: 38739404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. North Carolina community pharmacists' buprenorphine dispensing practices and attitudes.
    Carpenter D; Lambert KV; Harless JC; Wilson CG; Davis SA; Zule WA; Ostrach B
    J Am Pharm Assoc (2003); 2022; 62(5):1606-1614. PubMed ID: 35643625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers.
    Devane C; Renner RM; Munro S; Guilbert É; Dunn S; Wagner MS; Norman WV
    Pilot Feasibility Stud; 2019; 5():126. PubMed ID: 31720004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication Abortion With Pharmacist Dispensing of Mifepristone.
    Grossman D; Baba CF; Kaller S; Biggs MA; Raifman S; Gurazada T; Rafie S; Averbach S; Meckstroth KR; Micks EA; Berry E; Raine-Bennett TR; Creinin MD
    Obstet Gynecol; 2021 Apr; 137(4):613-622. PubMed ID: 33706339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mifepristone (RU486) in Australian pharmacies: the ethical and practical challenges.
    Lee RY; Moles R; Chaar B
    Contraception; 2015 Jan; 91(1):25-30. PubMed ID: 25248673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provision of first-trimester medication abortion in 2019: Results from the Canadian abortion provider survey.
    Ennis M; Renner R; Guilbert E; Norman WV; Pymar H; Kean L; Carson A; Martin-Misener R; Dunn S
    Contraception; 2022 Sep; 113():19-25. PubMed ID: 35351448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rural and small metro area naloxone-dispensing pharmacists' attitudes, experiences, and support for a frontline public health pharmacy role to increase naloxone uptake in New York State, 2019.
    Tofighi B; Lekas HM; Williams SZ; Martino D; Blau C; Lewis CF
    J Subst Abuse Treat; 2021 Oct; 129():108372. PubMed ID: 34080543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding access to medication abortion through pharmacy dispensing of mifepristone: Primary care perspectives from Illinois.
    Rasmussen KN; Janiak E; Cottrill AA; Stulberg DB
    Contraception; 2021 Jul; 104(1):98-103. PubMed ID: 33781760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.
    Thornton JD; Lyvers E; Scott VGG; Dwibedi N
    J Am Pharm Assoc (2003); 2017; 57(2S):S12-S18.e4. PubMed ID: 28163027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of costs to dispense prescriptions in independently owned, closed-door long-term care pharmacies.
    Carroll NV; Rupp MT; Holdford DA
    J Manag Care Spec Pharm; 2014 Mar; 20(3):291-300. PubMed ID: 24564809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication abortion: Advocating for mifepristone dispensing by pharmacists.
    Stone RH; Rafie S
    Contraception; 2021 Jul; 104(1):31-32. PubMed ID: 33971150
    [No Abstract]   [Full Text] [Related]  

  • 20. Obstetrician-gynecologist willingness to provide medication abortion with removal of the in-person dispensing requirement for mifepristone.
    Daniel S; Schulkin J; Grossman D
    Contraception; 2021 Jul; 104(1):73-76. PubMed ID: 33811840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.